Sentiment-Signal
27,4
Bearisch
Composite Score (0–100)
Insider (25%)
0
Keine Insider-Käufe
Institutionell (22,5%)
10.1
Keine neuen Positionen
Aktivist (12,5%)
0
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,70% (Stand: 31.03.2026)
Score-Verlauf (90 Tage)
Stammdaten
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19; Teriparatide injection product for osteoporosis; Vaxneuvance for the prevention of invasive disease caused by Streptococcus pneumoniae; and Pneumosil, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia among children. The company also offers Rylaze, a recombinant erwinia asparaginase for the treatment of acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; and Nexterone, a captisol-enabled formulation of amiodarone; and Zulresso, a captisol-enabled formulation of brexanolone for the treatment of postpartum depression. In addition, it provides Noxafil-IV, a captisol-enabled formulation of posaconazole for IV use; Duavee for the treatment of postmenopausal osteoporosis; Aziyo portfolio of commercial pericardial repair and CanGaroo envelope extracellular matrix products; Exemptia for autoimmune diseases; Vivitra for breast cancer; Bryxta and Zybev for various indications; and Minnebro for the treatment of hypertension. The company's partners and licenses programs, which are in clinical development used for the treatment of cancer, seizure, diabetes, cardiovascular disease, muscle wasting, liver and kidney disease, and other diseases. Further, it sells Captisol materials. The company was incorporated in 1987 and is headquartered in Emeryville, California.
Unternehmen & Branche
| Name | LIGAND PHARMACEUTICALS INC |
|---|---|
| Ticker | LGND |
| CIK | 0000886163 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Biotechnology |
| SIC | 2834 · Pharmaceutical Preparations |
Wertpapier & Kennzahlen
| CUSIP | 53220K215 |
|---|---|
| ISIN | US53220K2151 |
| Typ | Common Stock |
| Marktkapitalisierung | 4,65 Mrd. USD |
| Beta | 1,00 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | 268,087,000 | 124,453,000 | 6.13 | 1,560,637,000 | 1,017,212,000 |
| 2025-09-30 | 10-Q | 115,461,000 | 117,273,000 | 5.68 | 1,476,772,000 | 950,171,000 |
| 2025-06-30 | 10-Q | 47,627,000 | 4,847,000 | 0.24 | 948,604,000 | 827,313,000 |
| 2025-03-31 | 10-Q | 45,333,000 | -42,451,000 | -2.21 | 905,435,000 | 795,594,000 |
| 2024-12-31 | 10-K | 167,133,000 | -4,032,000 | -0.22 | 941,774,000 | 830,439,000 |
| 2024-09-30 | 10-Q | 51,812,000 | -7,172,000 | -0.39 | 954,866,000 | 841,178,000 |
| 2024-06-30 | 10-Q | 41,531,000 | -51,911,000 | -2.88 | 866,405,000 | 775,198,000 |
| 2024-03-31 | 10-Q | 30,978,000 | 86,139,000 | 4.75 | 913,869,000 | 806,521,000 |
| 2023-12-31 | 10-K | 131,314,000 | 52,154,000 | 2.94 | 787,216,000 | 700,913,000 |
| 2023-09-30 | 10-Q | 32,868,000 | -10,273,000 | -0.59 | 769,226,000 | 667,896,000 |
| 2023-06-30 | 10-Q | 26,366,000 | 2,290,000 | 0.13 | 758,105,000 | 664,892,000 |
| 2023-03-31 | 10-Q | 43,979,000 | 41,949,000 | 2.33 | 811,076,000 | 646,317,000 |
| 2022-12-31 | 10-K | 50,382,000 | -17,485,000 | -1.98 | 762,668,000 | 597,485,000 |
| 2022-09-30 | 10-K | 59,221,000 | 404,000 | |||
| 2022-09-30 | 10-Q | 59,221,000 | 404,000 | 0.02 | 1,050,605,000 | 816,298,000 |
| 2022-06-30 | 10-Q | 50,126,000 | -895,000 | -0.05 | 1,076,288,000 | 802,365,000 |
| 2022-06-30 | 10-K | 50,126,000 | -895,000 | |||
| 2022-03-31 | 10-Q | 36,516,000 | -15,385,000 | -0.91 | 1,105,184,000 | 793,192,000 |
| 2022-03-31 | 10-K | 36,516,000 | -15,385,000 | |||
| 2021-12-31 | 10-K | 56,404,000 | -5,417,000 | 3.31 | 1,297,590,000 | 821,159,000 |
Fondsaktivität (Vorquartalsvergleich)
| Fonds | Aktuell (Stk) | Vorquartal (Stk) | Veränderung (Stk) | Wert (USD) | Status | Δ | Trend |
|---|---|---|---|---|---|---|---|
| BlackRock, Inc. | 2,940,231 | 0 | 2,940,231 | 555,909,475 | Neu | +100,0% | |
| VANGUARD GROUP INC | 2,073,892 | 0 | 2,073,892 | 392,110,761 | Neu | +100,0% | |
| JANUS HENDERSON GROUP PLC | 995,400 | 0 | 995,400 | 188,199,064 | Neu | +100,0% | |
| STATE STREET CORP | 751,205 | 0 | 751,205 | 142,030,329 | Neu | +100,0% | |
| FMR LLC | 579,155 | 0 | 579,155 | 109,500,870 | Neu | +100,0% | |
| Invesco Ltd. | 516,464 | 0 | 516,464 | 97,647,849 | Neu | +100,0% | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 507,019 | 0 | 507,019 | 95,862,082 | Neu | +100,0% | |
| Stephens Investment Management Group LLC | 501,040 | 0 | 501,040 | 94,731,633 | Neu | +100,0% | |
| FRANKLIN RESOURCES INC | 496,160 | 0 | 496,160 | 93,808,984 | Neu | +100,0% | |
| GEODE CAPITAL MANAGEMENT, LLC | 493,589 | 0 | 493,589 | 93,336,090 | Neu | +100,0% | |
| CONGRESS ASSET MANAGEMENT CO | 480,063 | 0 | 480,063 | 90,765,511 | Neu | +100,0% | |
| DIMENSIONAL FUND ADVISORS LP | 432,992 | 0 | 432,992 | 81,867,024 | Neu | +100,0% | |
| GOLDMAN SACHS GROUP INC | 429,004 | 0 | 429,004 | 81,111,786 | Neu | +100,0% | |
| LOOMIS SAYLES & CO L P | 382,677 | 0 | 382,677 | 72,352,740 | Neu | +100,0% | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 363,584 | 0 | 363,584 | 68,742,827 | Neu | +100,0% | |
| DEUTSCHE BANK AG\ | 307,871 | 0 | 307,871 | 58,209,169 | Neu | +100,0% | |
| Ranger Investment Management, L.P. | 269,983 | 0 | 269,983 | 51,045,686 | Neu | +100,0% | |
| VICTORY CAPITAL MANAGEMENT INC | 256,410 | 0 | 256,410 | 48,479,439 | Neu | +100,0% | |
| NORTHERN TRUST CORP | 250,640 | 0 | 250,640 | 47,388,504 | Neu | +100,0% | |
| ASHFORD CAPITAL MANAGEMENT INC | 213,778 | 0 | 213,778 | 40,419,006 | Neu | +100,0% | |
| MORGAN STANLEY | 193,402 | 0 | 193,402 | 36,566,798 | Neu | +100,0% | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 184,284 | 0 | 184,284 | 34,842,576 | Neu | +100,0% | |
| Impax Asset Management Group plc | 165,208 | 0 | 165,208 | 31,235,877 | Neu | +100,0% | |
| UBS Group AG | 143,067 | 0 | 143,067 | 27,049,678 | Neu | +100,0% | |
| WELLS FARGO & COMPANY/MN | 132,636 | 0 | 132,636 | 25,077,394 | Neu | +100,0% | |
| Fiera Capital Corp | 131,236 | 0 | 131,236 | 24,812,790 | Neu | +100,0% | |
| Fisher Asset Management, LLC | 130,858 | 0 | 130,858 | 24,741,321 | Neu | +100,0% | |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 126,754 | 0 | 126,754 | 23,965,379 | Neu | +100,0% | |
| BANK OF MONTREAL /CAN/ | 126,063 | 0 | 126,063 | 23,834,730 | Neu | +100,0% | |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 122,326 | 0 | 122,326 | 23,128,177 | Neu | +100,0% | |
| BANK OF AMERICA CORP /DE/ | 120,169 | 0 | 120,169 | 22,720,258 | Neu | +100,0% | |
| Aberdeen Group plc | 119,309 | 0 | 119,309 | 22,557,752 | Neu | +100,0% | |
| ROYAL BANK OF CANADA | 108,796 | 0 | 108,796 | 20,569,000 | Neu | +100,0% | |
| Legal & General Group Plc | 108,383 | 0 | 108,383 | 20,491,974 | Neu | +100,0% | |
| NEW YORK STATE COMMON RETIREMENT FUND | 107,530 | 0 | 107,530 | 20,330,697 | Neu | +100,0% | |
| AMERIPRISE FINANCIAL INC | 98,264 | 0 | 98,264 | 18,578,777 | Neu | +100,0% | |
| PRINCIPAL FINANCIAL GROUP INC | 93,830 | 0 | 93,830 | 17,740,438 | Neu | +100,0% | |
| Allspring Global Investments Holdings, LLC | 71,818 | 0 | 71,818 | 13,653,320 | Neu | +100,0% | |
| Dana Investment Advisors, Inc. | 69,396 | 0 | 69,396 | 13,120,702 | Neu | +100,0% | |
| PUBLIC SECTOR PENSION INVESTMENT BOARD | 68,114 | 0 | 68,114 | 12,878,314 | Neu | +100,0% | |
| CASTLEARK MANAGEMENT LLC | 66,736 | 0 | 66,736 | 12,617,776 | Neu | +100,0% | |
| Pictet Asset Management Holding SA | 64,386 | 0 | 64,386 | 12,546,711 | Neu | +100,0% | |
| KORNITZER CAPITAL MANAGEMENT INC /KS | 60,342 | 0 | 60,342 | 11,408,862 | Neu | +100,0% | |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 60,020 | 0 | 60,020 | 11,347,981 | Neu | +100,0% | |
| OSAIC HOLDINGS, INC. | 59,405 | 0 | 59,405 | 11,231,696 | Neu | +100,0% | |
| Granite Investment Partners, LLC | 57,926 | 0 | 57,926 | 10,952,069 | Neu | +100,0% | |
| RHUMBLINE ADVISERS | 56,736 | 0 | 56,736 | 10,727,041 | Neu | +100,0% | |
| JPMORGAN CHASE & CO | 56,590 | 0 | 56,590 | 10,699,471 | Neu | +100,0% | |
| NORDEA INVESTMENT MANAGEMENT AB | 53,725 | 0 | 53,725 | 10,188,946 | Neu | +100,0% | |
| SEI INVESTMENTS CO | 46,368 | 0 | 46,368 | 8,766,819 | Neu | +100,0% |
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-04-01 | KOZARICH JOHN W | Director | Open Market Sale | -146 | 199.97 | -29,196.34 | -20,0% | |
| 2026-04-01 | Reardon Andrew | Officer, CLO & Secretary | Open Market Sale | -1,302 | 199.72 | -260,038.17 | -178,1% | |
| 2026-04-01 | Reardon Andrew | Officer, CLO & Secretary | Open Market Sale | -1,238 | 200.94 | -248,767.31 | -170,4% | |
| 2026-04-01 | Reardon Andrew | Officer, CLO & Secretary | Open Market Sale | -963 | 203.22 | -195,702.59 | -134,0% | |
| 2026-04-01 | Reardon Andrew | Officer, CLO & Secretary | Open Market Sale | -700 | 201.90 | -141,327.97 | -96,8% | |
| 2026-04-01 | Reardon Andrew | Officer, CLO & Secretary | Open Market Sale | -460 | 198.85 | -91,470.68 | -62,6% | |
| 2026-04-01 | Reardon Andrew | Officer, CLO & Secretary | Open Market Sale | -337 | 204.50 | -68,917.38 | -47,2% | |
| 2026-04-01 | KOZARICH JOHN W | Director | Open Market Sale | -43 | 202.91 | -8,725.22 | -6,0% | |
| 2026-04-01 | KOZARICH JOHN W | Director | Open Market Sale | -40 | 201.24 | -8,049.40 | -5,5% | |
| 2026-04-01 | KOZARICH JOHN W | Director | Open Market Sale | -79 | 202.42 | -15,991.36 | -11,0% | |
| 2026-04-01 | KOZARICH JOHN W | Director | Open Market Sale | -159 | 204.26 | -32,477.77 | -22,2% | |
| 2026-03-11 | Espinoza Octavio | Officer, Chief Financial Officer | Open Market Sale | -3,057 | 225.00 | -687,825.00 | -471,0% | |
| 2026-03-06 | LAMATTINA JOHN L | Director | Open Market Sale | -2,161 | 200.76 | -433,842.36 | -297,1% | |
| 2026-03-04 | Espinoza Octavio | Officer, Chief Financial Officer | Open Market Sale | -2,457 | 207.91 | -510,823.08 | -349,8% | |
| 2026-03-04 | Espinoza Octavio | Officer, Chief Financial Officer | Open Market Sale | -1,588 | 206.89 | -328,541.96 | -225,0% | |
| 2026-03-04 | Espinoza Octavio | Officer, Chief Financial Officer | Open Market Sale | -1,457 | 205.79 | -299,841.42 | -205,3% | |
| 2026-03-04 | Espinoza Octavio | Officer, Chief Financial Officer | Open Market Sale | -950 | 201.73 | -191,640.27 | -131,2% | |
| 2026-03-04 | Espinoza Octavio | Officer, Chief Financial Officer | Open Market Sale | -743 | 204.74 | -152,125.46 | -104,2% | |
| 2026-03-04 | Espinoza Octavio | Officer, Chief Financial Officer | Open Market Sale | -699 | 198.71 | -138,894.93 | -95,1% | |
| 2026-03-04 | Reardon Andrew | Officer, CLO & Secretary | Open Market Sale | -1,446 | 208.12 | -300,939.06 | -206,1% | |
| 2026-03-04 | Reardon Andrew | Officer, CLO & Secretary | Open Market Sale | -1,142 | 208.87 | -238,532.28 | -163,3% | |
| 2026-03-04 | Reardon Andrew | Officer, CLO & Secretary | Open Market Sale | -612 | 207.01 | -126,689.45 | -86,8% | |
| 2026-03-04 | Reardon Andrew | Officer, CLO & Secretary | Open Market Sale | -460 | 205.18 | -94,381.88 | -64,6% | |
| 2026-03-04 | Reardon Andrew | Officer, CLO & Secretary | Open Market Sale | -340 | 206.37 | -70,164.78 | -48,0% | |
| 2026-03-04 | Reardon Andrew | Officer, CLO & Secretary | Open Market Sale | -300 | 201.70 | -60,510.00 | -41,4% | |
| 2026-03-04 | Reardon Andrew | Officer, CLO & Secretary | Open Market Sale | -207 | 199.96 | -41,390.89 | -28,3% | |
| 2026-03-04 | Reardon Andrew | Officer, CLO & Secretary | Open Market Sale | -200 | 204.17 | -40,834.00 | -28,0% | |
| 2026-03-04 | Reardon Andrew | Officer, CLO & Secretary | Open Market Sale | -100 | 199.01 | -19,900.50 | -13,6% | |
| 2026-03-04 | Reardon Andrew | Officer, CLO & Secretary | Open Market Sale | -100 | 197.70 | -19,769.54 | -13,5% | |
| 2026-03-04 | Reardon Andrew | Officer, CLO & Secretary | Open Market Sale | -93 | 200.62 | -18,657.89 | -12,8% | |
| 2026-03-04 | Espinoza Octavio | Officer, Chief Financial Officer | Open Market Sale | -3,413 | 208.80 | -712,620.75 | -488,0% | |
| 2026-03-04 | Espinoza Octavio | Officer, Chief Financial Officer | Open Market Sale | -698 | 201.09 | -140,363.54 | -96,1% | |
| 2026-03-04 | Espinoza Octavio | Officer, Chief Financial Officer | Open Market Sale | -697 | 202.79 | -141,342.75 | -96,8% | |
| 2026-03-04 | Espinoza Octavio | Officer, Chief Financial Officer | Open Market Sale | -668 | 203.63 | -136,023.97 | -93,2% | |
| 2026-03-04 | Espinoza Octavio | Officer, Chief Financial Officer | Open Market Sale | -53 | 200.08 | -10,604.12 | -7,3% | |
| 2026-03-03 | Sabba Stephen L | Director | Open Market Sale | -2,034 | 201.50 | -409,851.00 | -280,7% | |
| 2026-03-02 | KOZARICH JOHN W | Director | Open Market Sale | -204 | 199.69 | -40,736.64 | -27,9% | |
| 2026-03-02 | KOZARICH JOHN W | Director | Open Market Sale | -42 | 203.57 | -8,549.94 | -5,9% | |
| 2026-03-02 | KOZARICH JOHN W | Director | Open Market Sale | -83 | 201.65 | -16,736.72 | -11,5% | |
| 2026-03-02 | KOZARICH JOHN W | Director | Open Market Sale | -50 | 202.54 | -10,126.94 | -6,9% | |
| 2026-03-02 | KOZARICH JOHN W | Director | Open Market Sale | -47 | 197.14 | -9,265.57 | -6,3% | |
| 2026-03-02 | KOZARICH JOHN W | Director | Open Market Sale | -41 | 200.40 | -8,216.56 | -5,6% | |
| 2026-02-02 | KOZARICH JOHN W | Director | Open Market Sale | -39 | 191.00 | -7,449.00 | -5,1% | |
| 2026-02-02 | KOZARICH JOHN W | Director | Open Market Sale | -1 | 192.18 | -192.18 | -0,1% | |
| 2026-02-02 | KOZARICH JOHN W | Director | Open Market Sale | -23 | 195.61 | -4,498.92 | -3,1% | |
| 2026-02-02 | KOZARICH JOHN W | Director | Open Market Sale | -23 | 197.20 | -4,535.49 | -3,1% | |
| 2026-02-02 | KOZARICH JOHN W | Director | Open Market Sale | -381 | 196.36 | -74,814.46 | -51,2% | |
| 2026-01-02 | KOZARICH JOHN W | Director | Open Market Sale | -207 | 190.27 | -39,385.95 | -27,0% | |
| 2026-01-02 | KOZARICH JOHN W | Director | Open Market Sale | -102 | 188.96 | -19,274.20 | -13,2% | |
| 2026-01-02 | KOZARICH JOHN W | Director | Open Market Sale | -91 | 187.95 | -17,103.78 | -11,7% | |
| 2026-01-02 | KOZARICH JOHN W | Director | Open Market Sale | -46 | 192.40 | -8,850.17 | -6,1% | |
| 2026-01-02 | KOZARICH JOHN W | Director | Open Market Sale | -21 | 186.59 | -3,918.39 | -2,7% | |
| 2025-12-12 | Espinoza Octavio | Officer, Chief Financial Officer | Open Market Sale | -1,804 | 188.31 | -339,711.24 | -232,6% | |
| 2025-12-01 | KOZARICH JOHN W | Director | Open Market Sale | -4 | 196.35 | -785.38 | -0,5% | |
| 2025-12-01 | KOZARICH JOHN W | Director | Open Market Sale | -23 | 199.22 | -4,581.95 | -3,1% | |
| 2025-12-01 | KOZARICH JOHN W | Director | Open Market Sale | -179 | 194.76 | -34,861.72 | -23,9% | |
| 2025-12-01 | KOZARICH JOHN W | Director | Open Market Sale | -92 | 197.72 | -18,189.95 | -12,5% | |
| 2025-12-01 | KOZARICH JOHN W | Director | Open Market Sale | -92 | 193.86 | -17,834.91 | -12,2% | |
| 2025-12-01 | KOZARICH JOHN W | Director | Open Market Sale | -47 | 195.80 | -9,202.54 | -6,3% | |
| 2025-12-01 | KOZARICH JOHN W | Director | Open Market Sale | -30 | 200.02 | -6,000.46 | -4,1% | |
| 2025-11-07 | Gray Nancy Ryan | Director | Open Market Sale | -3,556 | 205.45 | -730,580.20 | -500,3% | |
| 2025-11-07 | LAMATTINA JOHN L | Director | Open Market Sale | -2,145 | 205.45 | -440,690.25 | -301,8% | |
| 2025-11-07 | LAMATTINA JOHN L | Director | Open Market Sale | -2,034 | 205.45 | -417,885.30 | -286,2% | |
| 2025-11-07 | Gray Nancy Ryan | Director | Open Market Sale | -3,015 | 205.45 | -619,431.75 | -424,2% | |
| 2025-11-03 | KOZARICH JOHN W | Director | Open Market Sale | -84 | 189.00 | -15,875.73 | -10,9% | |
| 2025-11-03 | KOZARICH JOHN W | Director | Open Market Sale | -207 | 191.25 | -39,588.63 | -27,1% | |
| 2025-11-03 | KOZARICH JOHN W | Director | Open Market Sale | -127 | 192.38 | -24,432.02 | -16,7% | |
| 2025-11-03 | KOZARICH JOHN W | Director | Open Market Sale | -49 | 190.26 | -9,322.64 | -6,4% | |
| 2025-10-01 | KOZARICH JOHN W | Director | Open Market Sale | -92 | 181.18 | -16,668.91 | -11,4% | |
| 2025-10-01 | KOZARICH JOHN W | Director | Open Market Sale | -196 | 178.41 | -34,967.40 | -23,9% | |
| 2025-10-01 | KOZARICH JOHN W | Director | Open Market Sale | -155 | 180.01 | -27,901.52 | -19,1% | |
| 2025-10-01 | KOZARICH JOHN W | Director | Open Market Sale | -24 | 177.60 | -4,262.52 | -2,9% | |
| 2025-09-23 | Aryeh Jason | Director | Open Market Sale | -4,418 | 170.41 | -752,849.73 | -515,6% | |
| 2025-09-23 | Aryeh Jason | Director | Open Market Sale | -4,628 | 170.96 | -791,222.78 | -541,8% | |
| 2025-09-23 | Aryeh Jason | Director | Open Market Sale | -954 | 171.92 | -164,015.21 | -112,3% | |
| 2025-09-02 | KOZARICH JOHN W | Director | Open Market Sale | -85 | 164.25 | -13,961.08 | -9,6% | |
| 2025-09-02 | KOZARICH JOHN W | Director | Open Market Sale | -267 | 161.51 | -43,124.10 | -29,5% | |
| 2025-09-02 | KOZARICH JOHN W | Director | Open Market Sale | -115 | 162.52 | -18,689.66 | -12,8% | |
| 2025-08-01 | KOZARICH JOHN W | Director | Open Market Sale | -467 | 131.88 | -61,585.86 | -42,2% | |
| 2025-07-10 | KOZARICH JOHN W | Director | Open Market Sale | -934 | 125.00 | -116,750.00 | -80,0% | |
| 2025-06-23 | Reardon Andrew | Officer, CLO & Secretary | Open Market Sale | -500 | 114.08 | -57,042.15 | -39,1% | |
| 2025-06-10 | Reardon Andrew | Officer, CLO & Secretary | Open Market Sale | -500 | 114.54 | -57,270.70 | -39,2% | |
| 2025-05-15 | Reardon Andrew | Officer, CLO & Secretary | Open Market Sale | -1,000 | 104.00 | -104,000.00 | -71,2% | |
| 2025-05-09 | Davis Todd C | Director, Officer, Chief Executive Officer | Open Market Purchase | 1,680 | 104.57 | 175,677.60 | +120,3% | |
| 2025-05-09 | Espinoza Octavio | Officer, Chief Financial Officer | Open Market Purchase | 1,000 | 103.89 | 103,890.00 | +71,1% | |
| 2025-05-09 | Espinoza Octavio | Officer, Chief Financial Officer | Open Market Purchase | 500 | 104.40 | 52,200.00 | +35,7% | |
| 2025-05-09 | Davis Todd C | Director, Officer, Chief Executive Officer | Open Market Purchase | 5,523 | 105.67 | 583,629.22 | +399,7% | |
| 2025-05-09 | Davis Todd C | Director, Officer, Chief Executive Officer | Open Market Purchase | 2,307 | 104.53 | 241,149.56 | +165,1% |
Top-Fondshalter
Hinweis: Keine aktuelleren Daten zu dieser Aktie verfuegbar. Stand der gezeigten 13F-Holdings: 31.12.2025. Letztes global veroeffentlichtes 13F-Quartal: 31.03.2026.
| Fonds | Anteile | Wert (USD) | Anteil (%) |
|---|---|---|---|
| BlackRock, Inc. | 2,940,231 | 555,909,475 | 16.91 |
| VANGUARD GROUP INC | 2,073,892 | 392,110,761 | 11.92 |
| JANUS HENDERSON GROUP PLC | 995,400 | 188,199,064 | 5.72 |
| STATE STREET CORP | 751,205 | 142,030,329 | 4.32 |
| FMR LLC | 579,155 | 109,500,870 | 3.33 |
| Invesco Ltd. | 516,464 | 97,647,849 | 2.97 |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 507,019 | 95,862,082 | 2.92 |
| Stephens Investment Management Group LLC | 501,040 | 94,731,633 | 2.88 |
| FRANKLIN RESOURCES INC | 496,160 | 93,808,984 | 2.85 |
| GEODE CAPITAL MANAGEMENT, LLC | 493,589 | 93,336,090 | 2.84 |
| CONGRESS ASSET MANAGEMENT CO | 480,063 | 90,765,511 | 2.76 |
| DIMENSIONAL FUND ADVISORS LP | 432,992 | 81,867,024 | 2.49 |
| GOLDMAN SACHS GROUP INC | 429,004 | 81,111,786 | 2.47 |
| LOOMIS SAYLES & CO L P | 382,677 | 72,352,740 | 2.20 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 363,584 | 68,742,827 | 2.09 |
| DEUTSCHE BANK AG\ | 307,871 | 58,209,169 | 1.77 |
| Ranger Investment Management, L.P. | 269,983 | 51,045,686 | 1.55 |
| VICTORY CAPITAL MANAGEMENT INC | 256,410 | 48,479,439 | 1.47 |
| NORTHERN TRUST CORP | 250,640 | 47,388,504 | 1.44 |
| ASHFORD CAPITAL MANAGEMENT INC | 213,778 | 40,419,006 | 1.23 |